Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1-Cul1-F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins 1,2 . Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions 3,4 . The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the 40-amino-acid domain required for binding to Skp1) was first described 5 . Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs) 5-7 . However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein-substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCF Cyclin F ubiquitin ligase complex, leading to its degradation. siRNAmediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCF Cyclin F -mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.
To identify substrates of the SCF Cyclin F ubiquitin ligase, we transiently expressed FLAG-HA-tagged Cyclin F in cells from the human cell lines HeLa or HEK-293T and analysed the Cyclin F complex using immunopurification with Multidimensional Protein Identification Technology (MudPIT) 8 . In both cases, MudPIT revealed the presence of peptides corresponding to Skp1 and Cul1, whereas, in agreement with previous reports 6,9 , no peptides corresponding to CDKs were identified ( Supplementary Fig. 1a ). Instead, MudPIT revealed the presence of peptides derived from CP110 ( Supplementary Table 1 ). By combining both analyses, we identified 21 spectra, corresponding to 12 unique CP110 peptides. In two additional experiments, we immunopurified a Cyclin F mutant lacking the cyclin box (Cyclin F(1-270)), and although Skp1 and Cul1 still co-immunoprecipitated with Cyclin F(1-270), CP110 was not present ( Supplementary Table 1 ).
CP110 localizes to the distal ends of the centrioles, and its depletion interferes with centrosome re-duplication generated either by arresting cells in S phase for prolonged time periods or by overexpressing Plk4 (refs 10,11), indicating that CP110 has a pivotal role in the formation of new centrioles. Similarly, the fly orthologue of CP110 is necessary for both centriole duplication and centrosome maturation 12 . Finally, CP110 has additional roles in the regulation of centriole length and cilium formation 13,14 .
To investigate whether the binding between CP110 and Cyclin F is specific, we expressed in HEK-293T cells fourteen F-box proteins that were then immunoprecipitated to evaluate their interaction with CP110. We found that the only F-box protein able to co-immunoprecipitate endogenous CP110 was Cyclin F ( Supplementary Fig. 1b ). Using synchronized HeLa cells, we found that endogenous Cyclin F and endogenous CP110 interacted exclusively in the G2 and M phases, as monitored by immunoblotting for cell cycle markers and flow cytometry ( Fig. 1a and data not shown). Subsequently, we mapped the Cyclin F binding motif of CP110. A series of binding experiments, using multiple CP110 deletion mutants, narrowed the binding motif to a region of human CP110 located between amino acids 565 and 620 ( Supplementary Fig. 2 ). This region contains one putative RxL motif, an established cyclin binding domain. A CP110 with a mutation in this motif (CP110(RxL/AxA)) failed to co-immunoprecipitate endogenous Cyclin F ( Supplementary Fig. 2a ), indicating that the RxL motif, located at residues 588-590, mediates binding to Cyclin F. Cyclins recruit RxL-containing proteins through a hydrophobic patch in the cyclin box domain 15 . Cyclin F requires its cyclin box to bind endogenous CP110 ( Supplementary Fig. 3a, b and Supplementary Table 1 ). Moreover, Cyclin F has a conserved hydrophobic patch and a Cyclin F with a double mutation in this domain (Cyclin F(M/A;L/A)) lost the ability to bind CP110 ( Supplementary Fig. 3c, d) .
Because of the centrosomal localization of CP110, we investigated the subcellular localization of Cyclin F. We co-stained synchronized U-2OS cells (human osteosarcoma cell line) with antibodies to Cyclin F and c-tubulin (a centrosomal marker). As expected, cells in both S and G2 phase showed two c-tubulin dots, which were distinct (but adjacent) in S phase and separated by at least 2 mm in G2. We found that, similar to CP110 (refs 10,11.), endogenous Cyclin F partially colocalized with c-tubulin ( Fig. 1b) ; however, unlike CP110, which is exclusively centrosomal (refs 10,11, Fig. 1c and Supplementary Fig.  4 ), Cyclin F also localized to the nucleus. Moreover, Cyclin F staining on the centrosomes was rare in S phase cells and increased in G2 cells, whereas the intensity of CP110 staining was predominant in S phase and decreased in G2 phase ( Fig. 1b and Supplementary Fig. 4 ), correlating with the total CP110 levels detected by immunoblotting. We also observed that Cherry-Cyclin F colocalized with GFP-CP110 and was present on both the mother and daughter centrioles ( Fig. 1c ). Finally, we found that the centrosomal localization of Cyclin F does not require its binding to CP110 and is present at the amino terminus, as Cyclin F(1-270) and Cyclin F(M/A;L/A) (neither of which interacts with CP110) still localized to the centrioles, and Cyclin F(271-786) (which contains the CP110-binding domain) completely lost its centrosomal localization and binding to CP110 ( Supplementary Fig. 3a and data not shown).
As part of our investigation of CP110 binding to Cyclin F, we noticed that, compared to wild-type Cyclin F, the Cyclin F(LP/AA) mutant (in which the first two amino acids of the F-box domain were mutated to alanine) bound less Skp1 and Cul1 (as expected) but more CP110 ( Supplementary Fig. 3b ). This result indicated that CP110 might be targeted for proteolysis by Cyclin F, because Cyclin F(LP/AA) cannot form an active ubiquitin ligase; it can sequester CP110 in a more stable complex that is easier to detect.
In agreement with this interpretation, expression of wild-type Cyclin F resulted in a marked reduction in endogenous CP110 levels in four different cell lines. Moreover, expression of either Cyclin F(LP/AA) or Cyclin F(M/A;L/A) had no effect on CP110 levels ( Fig. 2a and Supplementary Fig. 5 ).
To test further whether Cyclin F might regulate the degradation of CP110, we used three different short interfering RNA (siRNA) oligonucleotides to reduce the expression of Cyclin F in synchronized HeLa cells. We also silenced Cyclin F expression in synchronized U-2OS and RPE1-hTERT cells (retinal pigmented epithelium cells immortalized with hTERT (human telomerase reverse transcriptase)) using the most effective of the three oligos. In all cases, depletion of Cyclin F inhibited the G2-specific degradation of CP110 ( Fig. 2b and Supplementary Fig. 6 ). Finally, immunopurified wildtype Cyclin F, but not Cyclin F(LP/AA), promoted the in vitro ubiquitylation of CP110 ( Fig. 2c) .
Together, the results in Figs 1 and 2 and Supplementary Figs 1-6 show that Cyclin F mediates the degradation of CP110 in G2 phase by forming an active SCF ubiquitin ligase complex.
To study the biological significance of Cyclin F-mediated degradation of CP110, we investigated whether overexpression of Cyclin F would affect centrosome reduplication in cells in which DNA synthesis is inhibited by hydroxyurea 16 . Therefore, we forced the expression of Cyclin F in U-2OS cells that were subsequently treated for 48 h with hydroxyurea, inducing a block in S phase (when endogenous protein levels are low ( Supplementary Fig. 7) and Cyclin F is rarely localized to the centrosome (Fig. 1b) ). Overexpression of Cyclin F induced its temporal mislocalization to the centrosome (not shown). Cells were analysed for centrosome number by dual-colour, indirect a, HeLa cells were synchronized at G1/S using a double-thymidine block before release into fresh medium. Cells were collected at the indicated times, lysed, immunoprecipitated with anti-Cyclin F antibody and immunoblotted as indicated. Last lane shows immunoprecipitation (IP) pre-incubated with the antigenic peptide. Left panel shows 10% of the material used for immunoprecipitations (input). b, U-2OS cells were synchronized as in a, fixed, and incubated with an anti-Cyclin F antibody (red) and anti-ctubulin antibody (green). The third panel shows staining after preincubation with the antigenic peptide. DNA was stained with DAPI. Insets show magnified views of the centrosomes indicated by arrows. Scale bar, 10 mM. The table shows the percentage of cells with centrosomal Cyclin F (where 100% was the total cells staining positive for nuclear Cyclin F) at different times after the release from the double-thymidine block (n < 50 per time point). c, Cyclin F and CP110 colocalize to the centrioles. U-2OS cells were transfected with GFP-CP110 and Cherry-Cyclin F. In merged images, yellow shows colocalization of CP110 and Cyclin F. Fig. 1a were then collected at the indicated times, lysed and immunoblotted as indicated. DNA content was monitored by flow cytometry. c, HEK-293T cells were transfected as in a, lysed, immunoprecipitated with anti-FLAG resin, and used in a ubiquitylation assay. NATURE | Vol 466 | 1 July 2010 LETTERS immunofluorescence using an antibody to c-tubulin and an antibody to Centrin 2 (a centriole marker). Control U-2OS cells that had been arrested in S phase underwent centrosome overduplication as determined by the presence of more than two c-tubulin foci and more than four Centrin 2 foci. By contrast, cells expressing high levels of Cyclin F did not show centrosome overduplication. Importantly, coexpression of a CP110 mutant that cannot bind Cyclin F reverted the Cyclin F-mediated inhibition of centrosome overduplication ( Supplementary Fig. 7) , indicating that Cyclin F acts as an inhibitor of centrosome reduplication by restraining the expression of CP110. In a complementary approach, we analysed synchronized and siRNA-treated U-2OS cells for centrosome defects. At both 9 and 12 h after release from a G1/S block (when most cells were in G2 and early M phases, respectively), treatment with siRNAs targeting Cyclin F produced a significant increase in the percentage of cells showing more than two c-tubulin foci and more than four foci for both Centrin 2 and CP110 ( Fig. 3a and Supplementary Fig. 8 ). Significantly, expression of a wild-type, but siRNA-insensitive, Cyclin F rescued the induction of excess CP110 dots. However, expression of the siRNA-resistant Cyclin F(M/A;L/A) failed to rescue the phenotype ( Supplementary Fig. 8 ). Finally, in agreement with the siRNA results, we observed that Cyclin F 2/2 mouse embryonic fibroblasts (MEFs) showed CP110 accumulation and an increased number of c-tubulin and Centrin 2 foci compared with Cyclin F Flox/-MEFs ( Supplementary Fig. 9 ).
During mitosis, the assembly of a bipolar spindle is mediated by the centrosomes (from which microtubules nucleate) and ensures the proper segregation of the genetic material. Cells react to centrosome overduplication by centrosome clustering, to prevent the formation of multipolar spindles [17] [18] [19] . However, before centrosome clustering, cells with extra centrosomes pass through transient, multipolar intermediates that promote merotelic and syntelic attachments, with consequent lagging chromosomes 20 . Therefore, we analysed mitotic figures using an antibody to a-tubulin (to stain mitotic spindles), an antibody to Centrin 2 and 49,6-diamidino-2-phenylindole (DAPI). Mitotic cells in which Cyclin F levels were reduced showed an increase in both multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes (Fig. 3b and Supplementary  Fig. 10 ). Significantly, when CP110 was silenced together with Cyclin F, the number of Centrin 2/c-tubulin foci and mitotic aberrations reverted to approximately control levels (Fig. 3a, b and Supplementary Figs 10, 11) , strongly indicating that the accumulation of CP110 during G2 phase in Cyclin F-depleted cells is responsible for the observed phenotypes.
To further investigate the effects produced by the failure to degrade CP110 in G2, we analysed synchronized U-2OS cells expressing either FLAG-tagged wild-type CP110 or FLAG-tagged CP110(RxL/AxA). Wild-type CP110 was degraded in G2 and M phase, whereas CP110(RxL/AxA), consistent with its inability to bind Cyclin F ( Supplementary Fig. 2) , was stable (Fig. 4a) . Importantly, expression of the stable CP110 mutant recapitulated the centrosome phenotypes observed upon Cyclin F silencing, namely an increased number of foci positive for Centrin 2, CP110 and c-tubulin (Fig. 4b) . Moreover, 100% of the mitotic cells that stained positive for CP110(RxL/AxA) showed abnormal spindles and lagging chromosomes (n 5 29/29), whereas only 25% of mitotic cells that did not express CP110(RxL/ AxA) showed mitotic aberrations (n 5 7/28) ( Fig. 4c ). Finally, expression of CP110(RxL/AxA) promoted the formation of micronuclei, a hallmark of chromosomal instability (Fig. 4d) .
Chromosome instability can result from centrosome overduplication [18] [19] [20] . Here, we show that a defect in the SCF Cyclin F -mediated degradation of CP110 results in centrosome and chromosome aberrations. Thus, we propose that Cyclin F helps to limit centrosome duplication to once per cell cycle to maintain chromosome stability.
Cyclin E is necessary for centrosome duplication (by an unknown mechanism) 21, 22 . Our results indicate that Cyclin F limits centrosome duplication by targeting CP110 for proteolysis. Thus, Cyclin E and Cyclin F have opposing roles, explaining why the former is expressed in S phase (when centrosome duplication occurs) and the latter in G2 phase (when centrosome duplication is restricted).
In summary, our study shows that Cyclin F forms an active SCF ubiquitin ligase complex (through its F-box motif), and it binds a, U-2OS cells were transfected with siRNAs to a LacZ, Cyclin F, or both Cyclin F and CP110, synchronized as in Fig. 1a , fixed at the indicated times after release from the block, and incubated with anti-Centrin 2 antibody (red) and anti-c-tubulin antibody (green). DNA was stained with DAPI. Insets show magnified views of centrosomes. Scale bar, 10 mm. The graphs on the right show quantification of three experiments. Error bars indicate 6s.d. *P 5 0.003; **P 5 0.001; ***P , 0.001. b, Experiments were performed as in a, except that cells were collected 14 h after release from the block and stained with anti-Centrin 2 antibody (red) and anti-a-tubulin antibody (green). Scale bar, 5 mm. The graphs on the right show the percentages of cells with various abnormal mitotic phenotypes. Error bars indicate 6s.d. *P , 0.001. CP110 using a mode of substrate recognition identical to that used by the canonical cyclins involved in protein phosphorylation (that is, through the hydrophobic patch in the cyclin box domain and the RxL motif in the substrate), thereby unifying the functions of the two Cyclin F homology domains. We show both temporal and spatial regulation of the SCF Cyclin F -mediated proteolysis of CP110 and demonstrate that this event has a physiological role in controlling genome integrity.
METHODS SUMMARY
Biochemical methods. Extract preparation, immunoprecipitation, and immunoblotting have been described 23, 24 . Plasmids. CP110 cDNA was from OpenBioSystems (clone MHS1010-7295919). Cyclin F cDNA was amplified by PCR using a cDNA library from HEK-293T cells. CP110 and Cyclin F mutants were generated either using the QuikChange Site-directed Mutagenesis kit (Stratagene) or by standard PCR methods. pCBF GFP-CP110 WT and CP110 truncation mutants were as described 10,13 . Immunofluorescence microscopy. For indirect immunofluorescence staining, cells were grown on glass coverslips and then fixed with methanol for 10 min. The cells were permeabilized with PBS/1% Triton X-100 for 10 min and blocked for 1 h in PBS/0.1% Triton X-100 containing 3% BSA before incubation with primary antibodies. Alexa Fluor 568-conjugated goat anti-rabbit and Alexa Fluor 488conjugated goat anti-mouse IgGs (Invitrogen) were used as secondary antibodies. DAPI was used to counterstain DNA. Slides were mounted with Prolong-Gold (Invitrogen). Image acquisition was performed using a Zeiss Axiovert 200 M microscope (63 3 objective lens, N.A. 1.4, 1.6 3 Optovar), equipped with a cooled Retiga 2000R CCD (QImaging). Mitotic images were deconvoluted using Metamorph (Molecular Devices). The images represent the maximum projection of 12 deconvoluted planes. Confocal microscopy (used in Fig. 2 and Supplementary Fig. 4 ) was performed using a Zeiss LSM 510, equipped with Zeiss LSM 510 software. 
